These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26514302)

  • 1. Influence of Gender on the Tolerability, Safety, and Efficacy of Quinidine Used for Treatment of Supraventricular and Ventricular Arrhythmias.
    Higgins AY; Waks JW; Josephson ME
    Am J Cardiol; 2015 Dec; 116(12):1845-51. PubMed ID: 26514302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
    Lee KL; Tai YT
    Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
    Viskin S; Chorin E; Viskin D; Hochstadt A; Halkin A; Tovia-Brodie O; Lee JK; Asher E; Laish-Farkash A; Amit G; Havakuk O; Belhassen B; Rosso R
    Circulation; 2019 May; 139(20):2304-2314. PubMed ID: 30696267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine pharmacodynamics in patients with arrhythmia: effects of left ventricular function.
    Gillis AM; Mitchell LB; Wyse DG; McDonald M; Duff HJ
    J Am Coll Cardiol; 1995 Apr; 25(5):989-94. PubMed ID: 7897143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias].
    Zehender M
    Z Kardiol; 1996; 85 Suppl 6():135-45. PubMed ID: 9064958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater quinidine-induced QTc interval prolongation in women.
    Benton RE; Sale M; Flockhart DA; Woosley RL
    Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ventricular and supraventricular arrhythmias in women].
    Janion M; Janion-Sadowska A
    Przegl Lek; 2014; 71(3):142-6. PubMed ID: 25154210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of Dofetilide From QT Prolongation and Ventricular Tachycardia in the Real World.
    Anand V; Vakil K; Tholakanahalli V; Li JM; McFalls E; Adabag S
    JACC Clin Electrophysiol; 2016 Dec; 2(7):777-781. PubMed ID: 29759759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of quinidine as salvage therapy for monomorphic ventricular tachycardia in patients with structural heart disease.
    Deshmukh A; Larson J; Ghannam M; Saeed M; Cunnane R; Ghanbari H; Latchamsetty R; Crawford T; Jongnarangsin K; Pelosi F; Chugh A; Oral H; Morady F; Bogun F; Liang JJ
    J Cardiovasc Electrophysiol; 2021 Dec; 32(12):3173-3178. PubMed ID: 34586686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy in supraventricular arrhythmia].
    Follath F; Candinas R; Meyer B
    Schweiz Rundsch Med Prax; 1992 Apr; 81(18):579-81. PubMed ID: 1594845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quinidine and high-amplification ECG].
    Brembilla-Perrot B; Beurrier D; Jacquemin L; Malak S; Danchin N
    Ann Cardiol Angeiol (Paris); 1997 Jan; 46(1):15-20. PubMed ID: 9092373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of encainide and quinidine for supraventricular tachyarrhythmias.
    Mäkynen PJ; Koskinen PJ; Saaristo TE; Liisanantti RK
    Am J Cardiol; 1988 Dec; 62(19):55L-59L. PubMed ID: 3144169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risks and side effects in treatment of supraventricular tachycardia].
    Lüderitz B
    Z Gesamte Inn Med; 1993 Sep; 48(9):459-65. PubMed ID: 8212752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.
    Pappone C; Vicedomini G; Augello G; Manguso F; Saviano M; Baldi M; Petretta A; Giannelli L; Calovic Z; Guluta V; Tavazzi L; Santinelli V
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):808-14. PubMed ID: 21946315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short QT syndrome: pharmacological treatment.
    Gaita F; Giustetto C; Bianchi F; Schimpf R; Haissaguerre M; Calò L; Brugada R; Antzelevitch C; Borggrefe M; Wolpert C
    J Am Coll Cardiol; 2004 Apr; 43(8):1494-9. PubMed ID: 15093889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnesium: current studies--critical evaluation--consequences].
    Meinertz T
    Z Kardiol; 1996; 85 Suppl 6():147-51. PubMed ID: 9064959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.